Dronedarone Rhythm Intervention for Early Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1898 participants.
Also called NCT07270848
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,898 participants
- Sponsor
- Registry
-
NCT07270848
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07270848. Randomized; no masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dronedarone Rhythm Intervention for Early Atrial Fibrillation
- Acronym
- DRIVE-AF
- Condition
- Atrial Fibrillation (AF)
- Intervention (Drug)
- Dronedarone
- Intervention (Drug)
- flecainide
- Intervention (Drug)
- propafenone
- Lead sponsor
- Inha University Hospital
Record details
- Record id
cardio:ct-nct07270848- Content hash
edf331fdee675ae57bbcf65ca0ff6ab7c6821be3cadf94098048a57d969e43a0